Clinical trial
Point-of-care Haemostasis Testing of Von Willebrand Factor Function Embedded in Catheterization Laboratory to Improve Real-time Management of Paravalvular Regurgitation During Minimally Invasive TAVI
NCT03728049 is registered in ClinicalTrials.gov with University Hospital, Lille as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Point-of-care Haemostasis Testing of Von Willebrand Factor Function Embedded in Catheterization Laboratory to Improve Real-time Management of Paravalvular Regurgitation During Minimally Invasive TAVI
- Lead sponsor
- University Hospital, Lille
- Phase
- Not applicable
- Overall status
- Recruiting
- Start date
- December 18, 2019
- Completion date
- December 31, 2026
- Enrollment
- 944 (estimated)
- Sites
- 9
Conditions
As the registry lists them; a condition with its own page is linked.